−1.20 CAD
−6.51 M CAD
0.00 CAD
39.57 M
About BRIACELL THERAPEUTICS CORP
Sector
Industry
CEO
William V. Williams
Website
Headquarters
West Vancouver
Founded
2006
FIGI
BBG000D9RW32
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where BCT is featured.
Frequently Asked Questions
The current price of BCT is 0.76 CAD — it has increased by 2.63% in the past 24 hours. Watch BRIACELL THERAPEUTICS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange BRIACELL THERAPEUTICS CORP stocks are traded under the ticker BCT.
BCT stock has fallen by −10.34% compared to the previous week, the month change is a −27.10% fall, over the last year BRIACELL THERAPEUTICS CORP has showed a −89.73% decrease.
BCT stock is 2.63% volatile and has beta coefficient of 1.88. Track BRIACELL THERAPEUTICS CORP stock price on the chart and check out the list of the most volatile stocks — is BRIACELL THERAPEUTICS CORP there?
Today BRIACELL THERAPEUTICS CORP has the market capitalization of 34.48 M, it has decreased by −12.64% over the last week.
Yes, you can track BRIACELL THERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
BCT net income for the last quarter is −7.92 M CAD, while the quarter before that showed −1.66 M CAD of net income which accounts for −376.48% change. Track more BRIACELL THERAPEUTICS CORP financial stats to get the full picture.
No, BCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 18.00 employees. See our rating of the largest employees — is BRIACELL THERAPEUTICS CORP on this list?
Like other stocks, BCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIACELL THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRIACELL THERAPEUTICS CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRIACELL THERAPEUTICS CORP stock shows the sell signal. See more of BRIACELL THERAPEUTICS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.